Dopamine transporters scanned using 123I-ioflupane at an early stage have significant diagnostic specificity for clinically uncertain parkinsonian syndromes (PS) and Parkinson disease (PD) [1, 2] and good sensitivity for dementia with Lewy bodies (DLB) [3]. This evidence concerns the gene SLC6A3 and Parkinson disease.